Treatment of Dyspareunia with Botulinum Neurotoxin Type A: Clinical Improvement and Influence of Patients’ Characteristics

The treatment of chronic pelvic pain (CPP) with botulinum neurotoxin type A (BoNT/A) has increased lately, but more studies assessing its effect are needed. This study aimed to evaluate the evolution of patients after BoNT/A infiltration and identify potential responders to treatment. Twenty-four wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarazona-Motes, Marta, Albaladejo-Belmonte, Monica, Nohales-Alfonso, Francisco J., De-Arriba, Maria, Garcia-Casado, Javier, Alberola-Rubio, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393724/
https://www.ncbi.nlm.nih.gov/pubmed/34444532
http://dx.doi.org/10.3390/ijerph18168783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393724/
https://www.ncbi.nlm.nih.gov/pubmed/34444532
http://dx.doi.org/10.3390/ijerph18168783

Ejemplares similares